A Randomized, Double-Blind, Split-Face, Clinical Trial of Angiopoietin-1 Derived Peptide Topical Following Fractional Radiofrequency Microneedling
Journal of Drugs in Dermatology · 01.09.2025 · 24 (9) · 875-884
DOI: 10.36849/jdd.8375 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Drugs in Dermatology, online erschienen am 01.08.2025. Verfasst von Catherine Di Giorgio und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Skin Aging, Angiopoietin-1, Cosmetic Techniques, Peptides. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Giorgio, C. D., Ramsay, K., Alsaafin, A., Radisic, M., & Ibrahimi, O. (2025). A Randomized, Double-Blind, Split-Face, Clinical Trial of Angiopoietin-1 Derived Peptide Topical Following Fractional Radiofrequency Microneedling. Journal of Drugs in Dermatology, 24(9), 875-884. https://doi.org/10.36849/jdd.8375
Vancouver
Giorgio CD, Ramsay K, Alsaafin A, Radisic M, Ibrahimi O. A Randomized, Double-Blind, Split-Face, Clinical Trial of Angiopoietin-1 Derived Peptide Topical Following Fractional Radiofrequency Microneedling. Journal of Drugs in Dermatology. 2025;24(9):875-884. doi:10.36849/jdd.8375
BibTeX
@article{Giorgio2025,
author = {Giorgio, Catherine Di and Ramsay, Kaitlyn and Alsaafin, Alaa and Radisic, Milica and Ibrahimi, Omar},
title = {A Randomized, Double-Blind, Split-Face, Clinical Trial of Angiopoietin-1 Derived Peptide Topical Following Fractional Radiofrequency Microneedling},
journal = {Journal of Drugs in Dermatology},
year = {2025},
volume = {24},
number = {9},
pages = {875--884},
doi = {10.36849/jdd.8375}
}
EUVIMED